Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125834401 | 12583440 | 1 | I | 20160714 | 20160722 | 20160722 | EXP | CA-ASTRAZENECA-2016SE77165 | ASTRAZENECA | 0.00 | M | Y | 0.00000 | 20160722 | CN | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125834401 | 12583440 | 1 | PS | ROSUVASTATIN. | ROSUVASTATIN | 1 | Oral | U | 21366 | TABLET | |||||||||
125834401 | 12583440 | 2 | SS | BRILINTA | TICAGRELOR | 1 | Oral | U | 0 | TABLET | |||||||||
125834401 | 12583440 | 3 | SS | BISOPROLOL | BISOPROLOL | 1 | Unknown | U | 0 | ||||||||||
125834401 | 12583440 | 4 | SS | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Unknown | U | 0 | ||||||||||
125834401 | 12583440 | 5 | SS | PERINDOPRIL ERBUMINE. | PERINDOPRIL ERBUMINE | 1 | Unknown | U | 0 | ||||||||||
125834401 | 12583440 | 6 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | 0 |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125834401 | 12583440 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125834401 | 12583440 | Asthma |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |